Neratinib (Compound)

Synonyms:Neratinib, 698387-09-6, HKI-272, Neratinib (HKI-272), Nerlynx, HKI 272, PB-272, JJH94R3PWB, (2E)-N-[4-[[3-chloro-4-[(pyridin-2-yl)methoxy]phenyl]amino]-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide, (E)-N-(4-(3-chloro-4-(pyridin-2-ylmethoxy)phenylamino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide, CHEMBL180022, CDP-820, 698387-09-6 (free base), HKI272, WAY-179272, (2E)-N-(4-{[3-chloro-4-(pyridin-2-ylmethoxy)phenyl]amino}-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide, (E)-N-(4-((3-Chloro-4-(pyridin-2-ylmethoxy)phenyl)amino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide, 876310-02-0, N-(4-(3-Chloro-4-(2-pyridinylmethoxy)anilino)-3-cyano-7-ethoxy-6-quinolyl)-4-(dimethylamino)-2-butenamide, (2e)-n-(4-((3-chloro-4-((pyridin-2-yl)methoxy)phenyl)amino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide, 2-Butenamide, N-(4-((3-chloro-4-(2-pyridinylmethoxy)phenyl)amino)-3-cyano-7-ethoxy-6-quinolinyl)-4-(dimethylamino)-, (2E)-, Neratinib [USAN], Neratinib(HKI-272), Neratinib [USAN:INN], UNII-JJH94R3PWB, Neratinib- Bio-X, (2E)-N-[4-({3-chloro-4-[(pyridin-2-yl)methoxy]phenyl}amino)-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide, (E)-N-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide, PB 272, NERATINIB [INN], NERATINIB [MI], Neratinib (USAN/INN), Neratinib - HKI-272, NERATINIB [MART.], NERATINIB [WHO-DD], SCHEMBL571762, SCHEMBL571763, GTPL5686, CHEBI:61397, AMY9255, DTXSID70220132, EX-A062, BCPP000151, BDBM50161957, MFCD09752958, NSC757439, NSC800803, s2150, WAY-179272-B, AKOS005146340, AKOS025149637, BCP9000984, CCG-270036, DB11828, NSC-757439, NSC-800803, NCGC00241101-01, NCGC00241101-03, NCGC00241101-09, AC-25073, AS-16279, BN164645, HY-32721, N1062, EC-000.2260, A25338, D08950, EN300-7386009, Q-101402, Q6995920, BRD-K85606544-001-01-8, (2e)-n-(4-((3-chloro-4-((pyridin-2-yl)methoxy)phenyl)amino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide neratinib, (2E)-N-[4-[[3-Chloro-4-(2-pyridinylmethoxy)phenyl]amino]-3-cyano-7-ethoxy-6-quinolinyl]-4-(dimethylamino)-2-butenamide, (E)-4-Dimethylamino-but-2-enoic acid {4-[3-chloro-4-(pyridin-2-ylmethoxy)-phenylamino]-3-cyano-7-ethoxy-quinolin-6-yl}-amide, 4-Dimethylamino-but-2-enoic acid {4-[3-chloro-4-(pyridin-2-ylmethoxy)-phenylamino]-3-cyano-7-ethoxy-quinolin-6-yl}-amide, HKI-272; PB272;;(2E)-N-[4-[[3-chloro-4-[(pyridin-2-yl)methoxy]phenyl]amino]-3-cyano-7-ethoxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide;HKI-272, N-(4-(3-chloro-4-(pyridin-2-ylmethoxy)phenylamino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)but-2-enamide, N-(4-(3-chloro-4-(pyridin-2-ylmethoxy)phenylamino)-3-cyano-7-ethoxyquinolin-6-yl)-4-(dimethylamino)butanamide
Id:9915743
Description:nan

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Neratinib's neighborhood in the knowledge graph.

Gene and Drug Landing Page Aggegrator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Neratinib.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Neratinib.

Results found

Linked to

 

Label

Description

 

Substance

A Substance

Collection

DrugPage Collection: (DrugCentralID:05252; PubChem_CID:9915743, FILE=drugcentral_drug_05252.json)

Collection

Metadatata for neratinib


  • Collection

    DrugPage Collection: (DrugCentralID:05252; PubChem_CID:9915743, FILE=drugcentral_drug_05252.json)


  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.